News
Event
GLP-1/GLP-1R AXIS TO TREAT OSTEOARTHRITIS A NEW OPPORTUNITY
Event
Spotlight on Our OARSI Congress Poster
Event
4Moving Biotech at OARSI 2025
Press Release
4Moving Biotech Secures €7.6M France 2030 Grant for Pioneering First-In-Class Disease-Modifying Osteoarthritis DrugÂ
Clinical Trial Press Release
Health Canada Authorizes 4Moving Biotech to Launch Phase 2a INFLAM MOTION Clinical Trial for Knee Osteoarthritis
Event
4Moving Biotech at ORS Annual Congress
End of content